Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2006; 12(36): 5866-5869
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5866
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5866
Condition | Requirements for diagnosis |
Hereditary haemochromatosis | Genotyped and / or biopsy proven |
Renal failure | Dialysis dependent |
Alcoholic liver disease (ALD) | Liver biopsy or Liver Function Test (LFT) abnormality compatible with ALD in patients with history of alcohol excess (> 30 u/wk) in whom other causes have been excluded |
Inflammatory disease | Raised C-Reactive Protein (CRP) and/or Erythrocyte Sedimentation Rate (ESR) on more than one consecutive test and recognised active inflammatory disease |
Repeated blood transfusion | More than 4 unit packed cell transfusion in preceding 6 mo |
Autoimmune disease | Recognised autoimmune disease with positive auto-antibody test |
Other liver disease | All other recognised causes of parenchymal liver damage with abnormal LFTs, excluding ALD and HHC |
Haematological disease | Bone marrow or blood film proven primary haematological disorder |
Neoplasia | Histologically proven neoplastic disease |
Weight loss | More than 10% body mass (kg) lost in preceding six months |
Human immuno-deficiency virus (HIV) | Positive HIV test |
- Citation: Hearnshaw S, Thompson NP, McGill A. The epidemiology of hyperferritinaemia. World J Gastroenterol 2006; 12(36): 5866-5869
- URL: https://www.wjgnet.com/1007-9327/full/v12/i36/5866.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i36.5866